Clindamycin PHOSPHATE aqua-solutum est Esther ad semisynthetic antibiotic produci in VII (S) per substitutionem -chloro-VII (R) -hydroxyl parens group et antibiotic, lincomycin. Inde est de lincomycin (a lincosamide). Hoc actum est in Asia, bacteriostatic praesertim affirmativa et lateque de aerobes anaerobicbacteria. Doses exprimantur basi Clindamycin 1G, phosphate clindamicina 1.2g.
PHOSPHATE Clindamycin
Clindamycin PHOSPHATE CAS: 24729-96-2
Donec Properties PHOSPHATE Clindamycin
MF: C18H34ClN2O8PS
MW: 504,96
EINECS: 246-433-0
Liquescens punctum, CXIV ° F
Ferventis punctum: ° c CLIX
Density: 1.41 ± 0.1 g / cm3 (praedictum est)
Refractivam index: CXXII ° (c = I, h2o)
Solubilitydmso: Soluble224mg / ml ad XXV ° c
Pka: pka 0.964 ± 0,06 (T = h2o XXI) (incerta); ± 0.06 6.06 (i = 0.008) (T = h2o XXI) (incertus)
Solubility aquam: aqua solutum libere
Merck Poland: 14,2356
Stabilitatem: Stabilis, sed frigus copia. Quae cum fortis oxidizing agentibus, calcium gluconate, barbiturates, magnesii sulfate, phenytoin, sodium coetus B vitamins.
Clindamycin PHOSPHATE CAS: 24729-96-2 Introduction:
Clindamycin adhibetur praesertim susceptibilis ad facies Infectiones anaerobic Bacteria; ex causa, inter tractus respiratorii infectiones, et mollis TEXTUS cutis infectiones, et peritonitis.In aegris cum hypersensitivity ad penicillins, ut clindamycin utendum facies tuberculosis susceptibilis ex causa etiam aerobic bacteria . Est etiam facies ad os et iuncturam tuberculosis et praecipue ex ea causa Staphylococcus aureus. General applicationem ad usus tractare potest ex clindamycin PHOSPHATE gloriam temperare, iracundiam mitis acne.
Clindamycin PHOSPHATE CAS: 24729-96-2 specification:
item |
specification |
test Results |
Characteres |
Album crystallinum pulveris |
obsequitur |
Lepidium sativum |
positive |
positive |
Rotatione Imprimis Gallium |
40mg / g aquae solution CL + + CXXXV ° F |
CXLV ° + |
pH |
0.1g / ml aquae solution pH3.0 5.0 ~ |
4.2 |
aqua |
Inter 6.0% 3.0 ~ |
4,2% |
Feria Sulphated |
â € ¤0,5% |
0,05% |
Related Composita |
Epiclindamycinâ ¤4.0-VII% |
0,5% |
Venis |
¥ â € 98.0% |
99,35% |
conclusioni |
In eventum quod est secundum vexillum |